Advances in Single-Cell Sequencing Technology and Its Applications in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is the most aggressive subtype of breast cancer and is mainly treated with chemotherapy-based combination therapy. In recent years, with the increasing development of global precision medicine, single-cell sequencing (SCS) has become one of the most promising tec...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Meng, Yan, Tingting, Wang, Miaozhou, Cai, Yanqiu, Wei, Yingyuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9760048/
https://www.ncbi.nlm.nih.gov/pubmed/36540278
http://dx.doi.org/10.2147/BCTT.S388534

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9760048/
https://www.ncbi.nlm.nih.gov/pubmed/36540278
http://dx.doi.org/10.2147/BCTT.S388534

Ejemplares similares